Instil Bio, Inc. - 8-K Filing
Instil Bio reports Q3 2026 net loss of $4.2 million and maintains cash runway through 2027. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $TIL
Read the full article at SEC EDGAR
Part of the story Cingulate Inc. - 8-K Filing (3 articles)